• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Need for Ocular Protection for Health Care Workers During SARS-CoV-2 Outbreak and a Hypothesis for a Potential Personal Protective Equipment.医护人员在 SARS-CoV-2 爆发期间对眼部保护的需求和对一种潜在个人防护设备的假设。
Front Public Health. 2020 Nov 12;8:599757. doi: 10.3389/fpubh.2020.599757. eCollection 2020.
2
[CONTACT LENS WEAR DURING THE COVID-19 (SARS-COV-2) ERA].[新冠疫情(严重急性呼吸综合征冠状病毒2)期间的隐形眼镜佩戴情况]
Harefuah. 2021 Feb;160(2):68-72.
3
[Respiratory and Facial Protection: Current Perspectives in the Context of the COVID-19 Pandemic].[呼吸道与面部防护:COVID-19大流行背景下的当前观点]
Acta Med Port. 2020 Sep 1;33(9):583-592. doi: 10.20344/amp.14108. Epub 2020 Jun 19.
4
Infection Prevention Precautions for Routine Anesthesia Care During the SARS-CoV-2 Pandemic.SARS-CoV-2 大流行期间常规麻醉护理的感染预防措施。
Anesth Analg. 2020 Nov;131(5):1342-1354. doi: 10.1213/ANE.0000000000005169.
5
Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.日本吞咽与吞咽困难学会:关于COVID-19疫情期间吞咽困难管理的立场声明。
Auris Nasus Larynx. 2020 Oct;47(5):715-726. doi: 10.1016/j.anl.2020.07.009. Epub 2020 Jul 23.
6
Survey and enlightenment on the wearing of protective equipment of nurses working on the front line against COVID-19.抗击新冠肺炎疫情一线护士防护用具使用情况的调查与启示
Medicine (Baltimore). 2021 May 14;100(19):e25924. doi: 10.1097/MD.0000000000025924.
7
[Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment].[新型冠状病毒肺炎病房环境及医务人员防护用品表面严重急性呼吸综合征冠状病毒2核酸污染的检测与评估]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Oct 18;52(5):803-808. doi: 10.19723/j.issn.1671-167X.2020.05.002.
8
The effect of eye protection on SARS-CoV-2 transmission: a systematic review.护眼对 SARS-CoV-2 传播的影响:系统综述。
Antimicrob Resist Infect Control. 2021 Nov 4;10(1):156. doi: 10.1186/s13756-021-01025-3.
9
A COVID-19 Exposure at a Dental Clinic Where Healthcare Workers Routinely Use Particulate Filtering Respirators.一家牙科诊所有 COVID-19 暴露事件,医护人员经常使用颗粒物过滤式呼吸器。
Int J Environ Res Public Health. 2021 Jun 16;18(12):6481. doi: 10.3390/ijerph18126481.
10
The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.新型冠状病毒肺炎的眼部表现及传播:预防建议
J Emerg Med. 2020 Jul;59(1):137-140. doi: 10.1016/j.jemermed.2020.04.060. Epub 2020 May 8.

引用本文的文献

1
New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention.纳米技术在新冠病毒检测、治疗策略及预防方面的新见解。
Mater Today Chem. 2023 Apr;29:101478. doi: 10.1016/j.mtchem.2023.101478. Epub 2023 Mar 3.
2
Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2.纳米工程工具在 SARS-CoV-2 的诊断、治疗、预防和缓解中的应用。
J Control Release. 2021 Oct 10;338:813-836. doi: 10.1016/j.jconrel.2021.08.046. Epub 2021 Aug 31.
3
Ocular Involvement of SARS-CoV-2 in a Polish Cohort of COVID-19-Positive Patients.波兰 COVID-19 阳性患者队列中 SARS-CoV-2 对眼部的影响。
Int J Environ Res Public Health. 2021 Mar 12;18(6):2916. doi: 10.3390/ijerph18062916.
4
Recent Advances on Nanomaterials to COVID-19 Management: A Systematic Review on Antiviral/Virucidal Agents and Mechanisms of SARS-CoV-2 Inhibition/Inactivation.纳米材料在COVID-19治疗中的最新进展:关于抗SARS-CoV-2病毒/杀病毒剂及抑制/灭活机制的系统综述
Glob Chall. 2021 Feb 22;5(5):2000115. doi: 10.1002/gch2.202000115. eCollection 2021 May.

本文引用的文献

1
Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin.抗病毒凝集素格里菲斯菌素的低成本大规模生产。
Front Bioeng Biotechnol. 2020 Aug 21;8:1020. doi: 10.3389/fbioe.2020.01020. eCollection 2020.
2
Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques.眼结膜接种 SARS-CoV-2 可在恒河猴中引起轻度 COVID-19。
Nat Commun. 2020 Sep 2;11(1):4400. doi: 10.1038/s41467-020-18149-6.
3
Natural protection of ocular surface from viral infections - A hypothesis.天然防护眼表免受病毒感染——一种假说。
Med Hypotheses. 2020 Oct;143:110082. doi: 10.1016/j.mehy.2020.110082. Epub 2020 Jul 9.
4
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.ACE2 和 TMPRSS2 在上皮细胞表面表达,提示其对 SARS-CoV-2 感染的易感性。
Ocul Surf. 2020 Oct;18(4):537-544. doi: 10.1016/j.jtos.2020.06.007. Epub 2020 Jun 13.
5
Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics.鉴定 SARS-CoV-2 刺突糖蛋白上的 22 个 N-糖基化位点和可及表面糖肽基序:对疫苗接种和抗体治疗的影响。
Glycobiology. 2021 Jan 9;31(1):69-80. doi: 10.1093/glycob/cwaa052.
6
Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface.SARS-CoV-2 进入基因在成人浅层眼表面结膜、角膜缘和角膜上皮中的共表达提示病毒可能通过眼表面进入人体的另一种途径。
Ocul Surf. 2021 Jan;19:190-200. doi: 10.1016/j.jtos.2020.05.013. Epub 2020 Jun 3.
7
COVID-19: Transmission, prevention, and potential therapeutic opportunities.新型冠状病毒肺炎:传播、预防和潜在治疗机会。
Clin Chim Acta. 2020 Sep;508:254-266. doi: 10.1016/j.cca.2020.05.044. Epub 2020 May 29.
8
Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.新型冠状病毒病 2019(SARS-CoV-2)与眼部组织和分泌物定植:系统评价。
Eye (Lond). 2020 Jul;34(7):1206-1211. doi: 10.1038/s41433-020-0926-9. Epub 2020 May 18.
9
Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.中国武汉 535 例 COVID-19 的眼部表现和临床特征:一项横断面研究。
Acta Ophthalmol. 2020 Dec;98(8):e951-e959. doi: 10.1111/aos.14472. Epub 2020 May 18.
10
Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients".新型冠状病毒肺炎中的低氧血症;评论:“SARS-CoV-2的神经侵袭潜力可能在新型冠状病毒肺炎患者的呼吸衰竭中起作用”
J Med Virol. 2020 Oct;92(10):1705-1706. doi: 10.1002/jmv.26020. Epub 2020 Jul 27.

医护人员在 SARS-CoV-2 爆发期间对眼部保护的需求和对一种潜在个人防护设备的假设。

The Need for Ocular Protection for Health Care Workers During SARS-CoV-2 Outbreak and a Hypothesis for a Potential Personal Protective Equipment.

机构信息

Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Public Health. 2020 Nov 12;8:599757. doi: 10.3389/fpubh.2020.599757. eCollection 2020.

DOI:10.3389/fpubh.2020.599757
PMID:33282819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7690622/
Abstract

SARS-CoV-2 is a coronavirus with high infectivity and has caused dramatic pressure on health systems all over the world. Appropriate personal protection for medical staffs is critical. For ocular protection, there is ongoing hot debate and concern for potential ocular transmission of SARS-CoV-2. Ocular manifestations and positive detection of viral RNA in ocular samples were only reported in very small number of patients infected with SARS-CoV-2. However, health care workers need to face patients more closely and have higher risk of aerosol contamination. Thus, appropriate ocular protection for medical workers is still recommended by organizations such as WHO and American Academy of Ophthalmology. Although eye goggles provide excellent protection and are mandatory for medical practitioners with high risk of exposure, they are not ideal for common clinical practice, because they can disturb vision due to extensive formation of water droplets and frequently cause moderate to severe discomfort after longtime wearing, which have been reported to interfere with working status. For the majority of medical workers who don't deal with high risk patients, they are not advised to wear goggles in daily practice. However, they also face the risk of infection due to the presence of asymptomatic carriers. Especially in situations with high risk of ocular exposure, such as close physical examination, eye surgery, dental clinics and surgery, ocular protection may be needed. Griffithsin has been shown to directly bind to spike proteins and has anti-viral activity against a broad spectrum of viruses, including coronavirus. Griffithsin is found to inhibit the entry of SARS-CoV at relatively low concentration and is stable and non-toxic. SARS-CoV-2 and SARS-CoV share the same entry receptors and their spike proteins are similar in conformation. We hypothesize that contact lenses containing nanoparticles loaded with griffithsin may provide sufficient ocular protection for medical staffs without high risk of exposure during the outbreak period of SARS-CoV-2. If proven effective, griffithsin-loaded contact lens can be considered as a supplementary ocular protective equipment for medical workers who can tolerate well. The daily disposable contact lens should be applied as needed and refrain from extended wearing in order to reduce potential side effects.

摘要

SARS-CoV-2 是一种具有高传染性的冠状病毒,已对全球卫生系统造成巨大压力。为医务人员提供适当的个人防护至关重要。对于眼部防护,人们对 SARS-CoV-2 可能通过眼部传播存在持续的热议和担忧。仅在少数感染 SARS-CoV-2 的患者中报告了眼部表现和眼部样本中病毒 RNA 的阳性检测。然而,医护人员需要更近距离地面对患者,并且气溶胶污染的风险更高。因此,世界卫生组织和美国眼科学会等组织仍建议医务人员进行适当的眼部防护。虽然护目镜能提供极好的保护,并且是高暴露风险医务人员的强制性装备,但它们并不适合常规临床应用,因为护目镜会因广泛形成的水滴而严重干扰视力,并且长时间佩戴后会经常引起中度至重度不适,据报道还会干扰工作状态。对于大多数不接触高危患者的医务人员,不建议他们在日常工作中佩戴护目镜。但是,由于存在无症状携带者,他们也面临感染的风险。特别是在存在高眼部暴露风险的情况下,如近距离体格检查、眼部手术、牙科诊所和手术,可能需要眼部防护。Griffithsin 已被证明可直接与刺突蛋白结合,并对包括冠状病毒在内的广谱病毒具有抗病毒活性。Griffithsin 被发现以较低的浓度抑制 SARS-CoV 的进入,并且稳定且无毒。SARS-CoV-2 和 SARS-CoV 使用相同的进入受体,其刺突蛋白在构象上相似。我们假设含有负载 griffithsin 的纳米颗粒的隐形眼镜可为在 SARS-CoV-2 爆发期间无高暴露风险的医务人员提供足够的眼部保护。如果被证明有效,那么载有 griffithsin 的隐形眼镜可被视为可耐受的医务人员的补充眼部防护设备。应按需使用日抛型隐形眼镜,并避免长时间佩戴,以减少潜在的副作用。